sameAs
The Metabolic Syndrome as a Risk Factor for Venous and Arterial Thrombosis"Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus FormationCombined deficiency of coagulation factors V and VIII: an updateThromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR)Piecing together the humoral and cellular mechanisms of immune thrombocytopeniaWarfarin pharmacogenetics: does more accurate dosing benefit patients?Patients' serum and urine as easily accessible samples for the measurement of non-vitamin K antagonist oral anticoagulantscis-elements required for expression of human protein C inhibitor gene in HepG2 cells and its androgen-dependent expression in rat reproductive organsAnticoagulation during pregnancyClopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosisPharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activityRole of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotectionAdverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting systemPlatelet function tests and flow cytometry to monitor antiplatelet therapyFlow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?Can platelet function tests predict the clinical efficacy of aspirin?Monitoring acetylsalicylic acid effects with the platelet function analyzer PFA-100Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100Detection of aspirin resistance by PFA-100: prevalence and aspirin compliance in patients with chronic stable anginaRetention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapyRole of the retention test Homburg in evaluating platelet hyperactivity and in monitoring therapy with antiplatelet drugsUse of the platelet reactivity index by Grotemeyer, platelet function analyzer, and retention test Homburg to monitor therapy with antiplatelet drugsInvestigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agentsState of the art--a journey through the world of antithrombotic therapyInherited thrombophilia and gestational vascular complicationsAcquired thrombophilia in pregnancy: essential thrombocythemiaThe hyperviscosity syndromesAnagrelide: what was new in 2004 and 2005?Update on diagnosis and management of essential thrombocythemiaTreatment of polycythemia veraThe utility of the PFA-100 in the identification of von Willebrand disease: a concise reviewThe paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia veraThe use of aspirin and clinical implications in essential thrombocythemiaHeparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humansControversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary interventionClinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implicationsAspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studiesRisk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia dataVascular complications in Chuvash polycythemiaVariable response to clopidogrel in patients with coronary artery disease
P1433
Q22250929-ACA4FAF2-7EC7-435B-847F-46695BEF19ACQ26786677-FCD9AB9F-1C41-407B-AA24-48028D1E5BD0Q26820265-8981745D-A374-4304-96FA-13E8702B8A7DQ26995284-3EF54251-AF40-4E7C-905A-F0BFF9F6723BQ27024841-CE7160A2-1AAB-453D-B4DF-8EA093571100Q27027304-85FCC587-55E4-4DFA-A3D4-D1D2ED595D3EQ28082944-B11D49B0-1BA2-4970-BEAB-F274696E11D4Q28144042-F1F3268A-C97F-4907-90A0-276573CBD1F0Q28166738-2552A0C6-942C-45B9-B4C4-7E1A7219B5A2Q28174320-C3FB0815-2049-40A7-8F55-187D971EEE74Q28174325-68642A5A-3B92-4E35-B7C4-17AC8FDCDCC8Q28174331-254B7191-DD67-4DEA-B9E1-CD623E814556Q28191185-8F8EE6D6-CE09-42DE-9109-55FB264EE6FBQ28191212-D27E28DE-FE8A-4EE0-A15B-585CF1F56164Q28191225-133DB1BA-6E44-47AA-843F-3A281D397F83Q28191243-5A8A8A39-F31B-4AD1-B711-A74DE2856CD2Q28191260-DD7C7571-ECE9-4AE8-9B96-ED55B015E5B2Q28191276-E5B9F821-0F10-48BF-9875-418F4C1EE03FQ28191296-8A8BB0C2-36AC-498B-B2CE-7084C4019D23Q28191318-3895D244-49B0-4DC0-AF6A-EDEF50A2A077Q28191347-340BB02D-9C20-4B4C-9A9B-F0E7AD0367B0Q28191375-257C5B1E-B7FF-48B7-9282-6A93120EF9D9Q28191399-92FEBD5A-76D6-4E12-A4AF-D6C77C27E7BBQ28193762-13BA76D5-6E30-44FD-83AC-AB2DF6708CDBQ28195731-C3DA5A14-AF17-476A-A328-0E8FBC471893Q28195732-E9486D23-BE17-4036-A1C8-58317D24AC2EQ28198225-C829F537-9A7F-4534-A05E-9E34AE293DD3Q28198694-504539BB-F77A-4498-9387-20977319F890Q28198700-A633C19F-28F6-43C5-A0B1-535DC679E174Q28198709-53FFDA70-F3CC-4A00-BEC1-C7C179D1CE75Q28199717-8756638E-8FD5-4630-9586-458F559A354FQ28200492-F7B0BA3A-1003-474D-A1EC-F500453D12A8Q28200493-8F3002BC-752C-49B4-8BF1-6FFBAE4D656CQ28205943-26957657-BC79-46B1-AFD4-FF3880AC5EB5Q28212543-FAF21B59-0DFC-4A95-80A9-D9B77DA17512Q28217454-10B2967D-2625-4F58-B70D-AAAD17564F88Q28217467-EC93BD68-0E33-4145-A7CF-ABC381E320CDQ28217474-E429F58C-155A-4731-A5FE-A42A28F60210Q28217478-5FC4872F-9D55-4B13-813F-8883A61B3B84Q28220118-BA78CFBC-9DA3-4CBA-9E8C-62AFF6E3E4C2
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Thieme Medical Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
英语期刊
@zh
name
Seminars in Thrombosis and Hemostasis
@ast
Seminars in Thrombosis and Hemostasis
@da
Seminars in Thrombosis and Hemostasis
@de
Seminars in Thrombosis and Hemostasis
@en
Seminars in Thrombosis and Hemostasis
@es
Seminars in Thrombosis and Hemostasis
@fi
Seminars in Thrombosis and Hemostasis
@fr
Seminars in Thrombosis and Hemostasis
@it
Seminars in Thrombosis and Hemostasis
@nb
Seminars in Thrombosis and Hemostasis
@nl
type
label
Seminars in Thrombosis and Hemostasis
@ast
Seminars in Thrombosis and Hemostasis
@da
Seminars in Thrombosis and Hemostasis
@de
Seminars in Thrombosis and Hemostasis
@en
Seminars in Thrombosis and Hemostasis
@es
Seminars in Thrombosis and Hemostasis
@fi
Seminars in Thrombosis and Hemostasis
@fr
Seminars in Thrombosis and Hemostasis
@it
Seminars in Thrombosis and Hemostasis
@nb
Seminars in Thrombosis and Hemostasis
@nl
prefLabel
Seminars in Thrombosis and Hemostasis
@ast
Seminars in Thrombosis and Hemostasis
@da
Seminars in Thrombosis and Hemostasis
@de
Seminars in Thrombosis and Hemostasis
@en
Seminars in Thrombosis and Hemostasis
@es
Seminars in Thrombosis and Hemostasis
@fi
Seminars in Thrombosis and Hemostasis
@fr
Seminars in Thrombosis and Hemostasis
@it
Seminars in Thrombosis and Hemostasis
@nb
Seminars in Thrombosis and Hemostasis
@nl
P3181
P4616
P1055
P1058
P1156
P1250
P1277
P1476
Seminars in Thrombosis and Hemostasis
@en